期刊
VIRUSES-BASEL
卷 9, 期 11, 页码 -出版社
MDPI
DOI: 10.3390/v9110339
关键词
EBV; apoptosis; genetic cooperation; latency; virus cancers; p53; BCL-2 family; growth transformation
类别
资金
- Cancer Research UK [C5575/A15032]
- Cancer Council Victoria [1086157]
- National Health and Medical Research Council [1086291]
- Estate of Anthony Redstone
- Cancer Research UK [15032] Funding Source: researchfish
- National Health and Medical Research Council of Australia [1086291] Funding Source: NHMRC
Epstein-Barr virus (EBV) was first discovered in cells from a patient with Burkitt lymphoma (BL), and is now known to be a contributory factor in 1-2% of all cancers, for which there are as yet, no EBV-targeted therapies available. Like other herpesviruses, EBV adopts a persistent latent infection in vivo and only rarely reactivates into replicative lytic cycle. Although latency is associated with restricted patterns of gene expression, genes are never expressed in isolation; always in groups. Here, we discuss (1) the ways in which the latent genes of EBV are known to modulate cell death, (2) how these mechanisms relate to growth transformation and lymphomagenesis, and (3) how EBV genes cooperate to coordinately regulate key cell death pathways in BL and lymphoblastoid cell lines (LCLs). Since manipulation of the cell death machinery is critical in EBV pathogenesis, understanding the mechanisms that underpin EBV regulation of apoptosis therefore provides opportunities for novel therapeutic interventions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据